NCT06560762View on ClinicalTrials.gov

Study in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

PHASE1RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 3, 2025

Primary Completion Date

December 15, 2025

Study Completion Date

December 15, 2025

Conditions
Heart Failure With Preserved Ejection Fraction (HFpEF)
Interventions
DRUG

STM01

Neonatal mesenchymal stem cells (nMSCs),

Trial Locations (2)

75390

RECRUITING

UT Southwestern Medical Center, Dallas

60611-5969

NOT_YET_RECRUITING

Northwestern Medicine, Chicago

Sponsors
All Listed Sponsors
lead

Secretome Therapeutics

INDUSTRY

NCT06560762 - Study in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) | Biotech Hunter | Biotech Hunter